25 results
424B5
IGMS
IGM Biosciences Inc
23 Jun 23
Prospectus supplement for primary offering
4:35pm
common stock as a position in a hedging transaction, “straddle,” “conversion transaction” or other risk reduction transaction;
persons who hold
424B5
IGMS
IGM Biosciences Inc
22 Jun 23
Prospectus supplement for primary offering
6:19am
or long-term residents of the United States;
persons who hold our common stock as a position in a hedging transaction, “straddle,” “conversion
424B3
gotgqdtbx tn28y61
8 Aug 22
Prospectus supplement
5:06pm
424B5
ge58 0bff1we
30 Mar 22
Prospectus supplement for primary offering
5:09pm
424B5
cclwb kpc3u8sk
29 Mar 22
Prospectus supplement for primary offering
7:36am
424B5
tmq6r8t
9 Dec 20
Prospectus supplement for primary offering
5:24pm
424B5
81y wykhk6f
7 Dec 20
Prospectus supplement for primary offering
5:28pm
S-3
von39k6d91
5 Nov 20
Shelf registration
7:47am
8-K
EX-3.1
24a34yoi
12 Jun 20
Amendments to Articles of Incorporation or Bylaws
5:11pm
8-K
EX-3.2
wbohgwkh5pry
20 Sep 19
IGM Biosciences Announces Closing of Initial Public Offering, Including Full
5:27pm
424B4
qphfx 2c82ooq222k4
18 Sep 19
Prospectus supplement with pricing info
4:43pm